This information was published on 2025-09-17T18:05:19 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2564826 (IR 1863623) |
| (220) |
17 Mar 2025
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 41
Provision of educational services relating to health; publication of the results of clinical trials; education services relating to therapeutic treatments. Class 42 Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about the results of clinical trials for pharmaceutical products; providing scientific information in the field of medical disorders and their treatment. Class 44 Provision of pharmaceutical information; provision of medical information. |
| (540) | RESPIMUNE |
| (550) | Word |
| (730) |
CSL Behring GmbH
|
Find out more about publications on the About page.